Objectives: Assess adverse perinatal outcomes in pregnant women living with HIV (WLHIV)
receiving HAART or zidovudine (ZDV) monotherapy, compared with antiretroviral therapy …

Background: Remarkable progress has been achieved in the identification of HIV infection in
pregnant women and in the prevention of vertical HIV transmission through maternal …

Abstract Background Human Immunodeficiency Virus (HIV) infection and low birth weight
(LBW) continue to be significant public health concerns in many low-income countries …

HIV infection is a clinically significant public health disease and contributes to increased risk
of maternal and fetal morbidity and mortality. HIV pregnancy studies use outcome measures …

Background Exposures to human immunodeficiency (HIV) and antiretroviral therapy in utero
may have adverse effects on infant growth. Among children born in Denmark and aged 0–5 …

BACKGROUND Pregnancy loss is poorly understood, but infection may be a risk factor. Few
studies have evaluated pregnancy loss among women living with HIV in the era of potent …

Objectives To estimate the effect of HIV infection on the risk of preterm birth (PTB) and low
birth weight (LBW) among Chinese pregnancy women. Design A retrospective cohort study …

Objectives: Infants who are HIV exposed but uninfected (HEU) compared with HIV
unexposed uninfected (HUU) have an increased risk of adverse birth outcomes, morbidity …

Objective This study aimed to evaluate the effects of in-utero exposure to HIV and ART on
pregnancy outcome and early growth of children. Methods This cohort study enrolled 802 …

Background Mother-to-child transmission is the primary cause of HIV cases among children.
Antiretroviral therapy (ART) plays a critical role in preventing mother-to-child transmission …